Max Str.nasal Relief Severe Congestion
Product Images NDC 11822-1232

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Max Str.nasal Relief Severe Congestion (NDC 11822-1232). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ride Aid, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Back)

Image Description (Back)
This text is a description of a nasal relief product. It contains instructions on how to use it, its active and inactive ingredients, as well as precautions and warnings. The product is designed to provide temporary relief from nasal congestion associated with the common cold, hay fever, and allergies. It is not suitable for children under one year old. The directions state to shake well before use and not to exceed the recommended dosage. The product is not meant to be shared with others, and if swallowed, medical attention should be sought immediately.*
FDA Label Image

Image Description (Front)

Image Description (Front)
This is a description of a nasal decongestant sold by Rite Aid. The decongestant contains oxymetazoline hydrochloride 0.05% and is intended to provide fast and powerful relief from severe congestion caused by colds or allergies. The decongestant is applied using a no-drip pump spray, which means it won't drip from the nose or down the throat. The package contains 1 FL OZ (30 mL) of the decongestant, and instructions for removing and reapplying the cap are provided on the bottle.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.